-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on VolitionRX, Maintains $5 Price Target

Benzinga·07/17/2025 12:39:20
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:VNRX) with a Buy and maintains $5 price target.